ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

FIXX Homology Medicines Inc

0,9347
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Homology Medicines Inc FIXX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 0,9347 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,9347 0,9347
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/3/202421:30GLOBEHomology Medicines Declares Distribution to Common..
11/3/202412:37EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202412:32EDGAR2Form 8-K - Current report
21/2/202422:04EDGAR2Form 425 - Prospectuses and communications, business..
15/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
13/2/202416:11EDGAR2Form S-4/A - Registration of securities, business..
05/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:29EDGAR2Form 425 - Prospectuses and communications, business..
03/1/202422:26EDGAR2Form 8-K - Current report
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:08GLOBEHomology Medicines Receives NASDAQ Notification Regarding..
17/11/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/11/202322:19EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202322:16EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202322:13EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:46EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:45EDGAR2Form 8-K - Current report
16/11/202313:17EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:16EDGAR2Form 8-K - Current report
16/11/202313:05PRNUSQ32 Bio and Homology Medicines Announce Merger Agreement
14/11/202322:33GLOBEHomology Medicines Reports Third Quarter 2023 Financial..
10/10/202323:22EDGAR2Form 8-K - Current report
08/9/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:05GLOBEHomology Medicines Reports Second Quarter 2023 Financial..
14/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202303:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202323:29EDGAR2Form 8-K - Current report
27/7/202322:05GLOBEHomology Medicines Announces Plan to Evaluate Strategic..
27/7/202322:01GLOBEHomology Medicines Announces Encouraging Initial Data from..
16/5/202314:00GLOBEHomology Medicines Announces First Data from IND-Enabling..

Dernières Valeurs Consultées

Delayed Upgrade Clock